Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma Biotechnology, Inc. 2023 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. - SEC Filings - Annual Reports & Proxies
Dennis Sanders - Senior Clinical Specialist - Puma Biotechnology, Inc. | LinkedIn
Exhibitor Puma Biotechnology 07-10 - Scripps CME Connection
Puma Biotechnology's (PBYI) Lowest Price: $1.6400 (on 05-11-2022)
Puma Biotechnology, Inc. | LinkedIn
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology, Inc. (PBYI) Company Information - Simply Wall St
PBYI Insider Trading Activity - Puma Biotechnology, Inc.
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Puma Biotechnology Inc
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
meenu soni - typing - Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology, Inc. 2020 Q1 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Surging
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology Inc Share Price USD0.0001
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Puma Biotechnology, Inc. 2021 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
